Table 1.
Characteristics of the included HCC patients.
| General characteristics | n = 25 | % |
|---|---|---|
| Age (years) | 59.40 ± 6.90 | |
| Gender (male) | 24 | 96 |
| HBsAg (+) | 20 | 80 |
| Anti-HCV (+) | 0 | 0 |
| Cirrhosis | 19 | 76 |
| AFP (> 20 ng/mL) | 12 | 48 |
| Tumour number | ||
| Solitary tumour | 15 | 60 |
| Multiple tumours | 10 | 40 |
| MVI | ||
| M0 | 2 | 8 |
| M1 | 8 | 32 |
| M2 | 10 | 40 |
| AJCC TNM stage | ||
| I | 5 | 20 |
| II | 10 | 40 |
| III | 4 | 16 |
| IV | 1 | 4 |
Five HCC patients whose diagnosis was based on non-invasive criteria underwent TACE instead of hepatic surgery and, therefore, had no pathological data. HBsAg, hepatitis B surface antigen; Anti-HCV, anti-hepatitis C virus antibody; AFP, α-fetoprotein; MVI, microvascular invasion; AJCC TNM, American Joint Committee on Cancer tumour-node-metastasis.